Home › NDC Lookup › RxCUI directory › RxCUI 847910

60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector — RxCUI 847910

RxNorm drug concept · Semantic clinical drug
RxCUI 847910 Semantic clinical drug · SCD ● Current RxNorm concept 4 FDA products 4 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI847910
Official name60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asexenatide 250 MCG/ML Pen Injector, 2.4 ML; exenatide 10 MCG, 250 MCG/ML in 2.4 mL Pen Injector; exenatide 10 MCG/ACTUAT Pen Injector, 60 ACTUAT
FDA products mapped4
Package NDCs mapped4
Reported Medicaid activity (SDUD)3,354 prescriptions · 17 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Exenatide Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • No, exenatide is not insulin. Instead of replacing insulin, it works like a natural gut hormone called GLP-1 to encourage your own pancreas to release insulin — but only when your...
  • What exactly does exenatide do — is it the same as insulin?
  • Yes, nausea is the most common side effect and it can be pretty bothersome at first, especially when you start or when your dose increases. The good news is that for most people it...
  • I feel nauseous when I take it — is that normal, and will it go away?
📖 Read our full Exenatide Injection guide →

🕸️ Concept Web — How 60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 60 ACTUAT exenatide 0.01 MG/ACTUAT Pen Injector RxCUI 847910

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Exenatide 60548
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Byetta 604751
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Exenatide Pen Injector 1653616
    • Exenatide Injectable Product 1163790
    • Exenatide Pen Injector [Byetta] 1653625
    • Byetta Injectable Product 1169415
    • Pen Injector 1649571
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Exenatide 0.01 MG/ACTUAT SCDC · 847908
  • Exenatide Pen Injector SCDF · 1653616
  • Exenatide Injectable Product SCDG · 1163790

Brand-Name Concepts

📦 FDA Products & Package NDCs

4 products · 4 package NDCs
4 package NDCs map to RxCUI 847910 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00310-6512-01 1 CARTRIDGE in 1 CARTON (0310-6512-01) / 1.2 mL in 1 CARTRI... Byetta AstraZeneca Pharmaceuticals LP 2014-12-10
00310-6524-01 1 CARTRIDGE in 1 CARTON (0310-6524-01) / 2.4 mL in 1 CARTRI... Byetta AstraZeneca Pharmaceuticals LP 2014-12-12
70121-1685-01 1 CARTRIDGE in 1 CARTON (70121-1685-1) / 1.2 mL in 1 CARTRI... Exenatide Amneal Pharmaceuticals LLC 2024-11-22
70121-1686-01 1 CARTRIDGE in 1 CARTON (70121-1686-1) / 2.4 mL in 1 CARTRI... Exenatide Amneal Pharmaceuticals LLC 2024-11-22
Observed labelers: Amneal Pharmaceuticals LLC (2) · AstraZeneca Pharmaceuticals LP (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per ml · median
$340.1010
Range $300.1680–$681.2630 · middle 50% $320.1345–$510.6820 · 3 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.